Tri-GalNAc-NHS ester is a multifunctional ligand designed to target the asialoglycoprotein receptor (ASGPR), which is highly expressed in hepatocytes. It features three N-acetylgalactosamine (GalNAc) clusters linked to an NHS ester group. This structure allows for efficient conjugation with amine-containing biomolecules, such as peptides, proteins, or nucleic acids, enabling the development of targeted drug delivery systems and lysosome-targeting chimeras (LYTACs). Its ability to bind ASGPR makes it a valuable tool for enhancing the uptake of therapeutic agents by liver cells, facilitating protein degradation, and improving the delivery efficiency of siRNA and other nucleic acid-based therapies.
Structure of 1953146-83-2
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.